Notice of Board meeting published on 14th January 2021 in Business Standard and Nava Telangana |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q3 FY 2020-21 |
Download
|
Notice of Board Meeting scheduled on 28th January 2021 |
Download
|
Outcome of Board Meeting dated 09th November 2020 |
Download
|
Disclosure of Related Party Transactions for the half year ended September 30, 2020 |
Download
|
Q2 Results for the FY 2020-21 Published in Business Standard and Nava Telangana on 21.10.2020 |
Download
|
Outcome of Board Meeting dated 20th October 2020 |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q2 FY 2020-21 |
Download
|
Notice of Board meeting published on 6th October 2020 in Business Standard and Nava Telangana |
Download
|
Notice of Board Meeting scheduled on 20th October 2020 |
Download
|
29th AGM Voting Results |
Download
|
Notice of 29th AGM published on 23rdJuly 2020 in Business Standard and Nava Telangana |
Download
|
Q1 Results for the FY 2020-21 Published in Business Standard and Prajashakti on 18.07.2020 |
Download
|
Outcome of Board Meeting dated 17th July 2020 |
Download
|
Notice of Board meeting published on 10th July 2020 in Business Standard and Prajashakti |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q1 FY 2020-21 |
Download
|
Notice of Board Meeting scheduled on 17th July 2020 |
Download
|
Disclosure of Related Party Transactions for the half year ended March 31, 2020 |
Download
|
Q4 Results for the FY 2019-20 Published in Business Standard and Prajashakti on 03.06.2020 |
Download
|
Outcome of Board Meeting dated 02nd June 2020 |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q4 FY 2019-20 |
Download
|
Notice of Board meeting published on 19th May 2020 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting scheduled on 02nd June 2020 |
Download
|
EU GMP approval received for Unit-V located at Visakhapatnam |
Download
|
Open Conference call update-26.03.2020 |
Download
|
Public Announcement for Buyback published in Business Standard and Nava Telangana on 12th March 2020 |
Download
|
Postal Ballot Results-10.03.2020 |
Download
|
Granules Pharmaceuticals, Inc. received US FDA approval for Potassium Chloride Extended-Release Tablets USP |
Download
|
Notice of Postal Ballot published on 8th February 2020 in Business Standard and Prajashakti |
Download
|
Postal Ballot Notice dated 21st January 2020 |
Download
|
Q3 Results for the FY 2019-20 Published in Business Standard and Prajashakti on 22.01.2020 |
Download
|
Outcome of Board Meeting held on 21st January 2020 |
Download
|
Intimation of Board meeting to consider buyback of shares |
Download
|
Notice of Board meeting published on 11th January 2020 in Business Standard and Prajashakti |
Download
|
Clarification on news item for re-call of Ranitidine |
Download
|
Notice of Board Meeting Scheduled on 21st January 2020 |
Download
|
Resignation of Mr. C. Parthasarathy, Independent Director |
Download
|
Approval of Loratadine tablets USP |
Download
|
Update on NDMA in Metformin |
Download
|
Clarification on presence of NDMA in Metformin |
Download
|
Clarification on News Item |
Download
|
Received EIR from US FDA for GPI Facility |
Download
|
Disclosure of Related Party Transactions for the half year ended September 30, 2019 |
Download
|
Q2 Results for the FY 2019-20 Published in Business Standard and Prajashakti on 23.10.2019 |
Download
|
Outcome of Board Meeting held on 22nd October 2019 |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q2 FY 2019-20 |
Download
|
Notice of Board meeting published on 15th October 2019 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting Scheduled on 22nd October 2019 |
Download
|
Outcome of Board Meeting held on 14th October 2019 |
Download
|
Postal Ballot Results-11.10.2019 |
Download
|
Received EIR from US FDA for Bonthapally Facility |
Download
|
Notice of Postal Ballot published on 11th September 2019 in Business Standard and Prajashakti |
Download
|
Postal Ballot Notice dated 29th August 2019 |
Download
|
28th AGM Voting results |
Outcome of Board Meeting held on 29th August 2019 |
Download
|
US FDA approved the ANDA filed by GPI for Amphetamine Sulfate Tablets |
Download
|
Notice of 28th AGM published on 3rd August 2019 in Business Standard and on 4th August 2019 in Prajashakti |
Download
|
Q1 Results for the FY 2019-20 Published in Business Standard and Prajashakti on 31.07.2019 |
Download
|
Outcome of Board Meeting held on 30th July 2019 |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q1 FY 2019-20 |
Download
|
Notice of Board meeting published on 20th July 2019 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting Scheduled on 30th July 2019 |
Download
|
Disclosure of Related Party Transactions for the half year ended March 31, 2019 |
Download
|
US FDA approved the ANDA filed by GPI for Methylphenidate Hydrochloride Extended-Release capsules |
Download
|
Q4 Results for the FY 2018-19 Published in Business Standard and Prajashakti on 10.05.2019 |
Download
|
Outcome of Board Meeting held on 9th May 2019 |
Download
|
Notice of Board meeting published on 4th May 2019 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting Scheduled on 9th May 2019 |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q4 FY 2018-19 |
Download
|
Notice of Trading window closure |
Download
|
Outcome of Board Meeting held on 29th March 2019 |
Download
|
: Q3 Results for the FY 2018-19 Published in Business Standard and Prajashakti on 30.01.2019 |
Download
|
Outcome of Board Meeting held on 29th January 2019 |
Download
|
Notice of Board meeting published on 22nd January 2019 in Business Standard and Prajashakti |
Download
|
Schedule of Analyst and Investor Earnings Conference call – Q3 FY 2018-19. |
Download
|
Notice of Board Meeting Scheduled on 29th January 2019 |
Download
|
Q2 Results for the FY 2018-19 Published in Business Standard and Prajashakti on 31.10.2018 |
Download
|
Outcome of Board Meeting held on 29th October 2018 |
Download
|
US FDA completed inspection in GPI |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q2-FY2018-19 |
Download
|
Notice of Board meeting published on 23rd October 2018 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting scheduled on 29th October 2018 |
Download
|
27th AGM Voting Results |
Download
|
Notice of 27th AGM published on 15th August 2018 in Business Standard and Prajashakti |
Download
|
Q1 Results for the FY 2018-19 Published in Business Standard and Prajashakti on 25.07.2018 |
Download
|
Outcome of Board Meeting held on 23rd July 2018 |
Download
|
Notice of Board meeting published on 17th July 2018 in Business Standard and Prajashakti |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q1-FY2018-19 |
Download
|
Notice of Board Meeting scheduled on 23rd July 2018 |
Download
|
Received EIR from US FDA to Gagillapur Facility |
Download
|
Q4 Results for the FY 2017-18 Published in Business Standard and Prajashakti on 25.05.2018 |
Download
|
Outcome of Board Meeting held on 24th May 2018 |
Download
|
Notice of Board meeting published on 19th May 2018 in Business Standard and Prajashakti |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q4-FY2017-18 |
Download
|
Notice of Board Meeting scheduled on 24th May 2018 |
Download
|
Received EIR from US FDA to Jeedimetla Facility |
Download
|
Approval for Methocarbamol |
Download
|
US FDA inspection at Gagillapur and Jeedimetla facilities |
Download
|
Approval for Metformin ER |
Download
|
Received EIR from US FDA to Granules Pharmaceuticals, Inc. facility |
Download
|
Q3 Results for the FY 2017-18 Published in Business Standard and Prajashakti on 09.02.2018 |
Download
|
Outcome of Board Meeting held on 8th February 2018 |
Download
|
Notice of Board meeting published on 1st February 2018 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting scheduled on 8th February 2018 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q3-FY2017-18 |
Download
|
Outcome of Board Meeting held on 9th November 2017 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q2-FY2017-18 |
Download
|
Notice of Board meeting published on 2nd Nov 2017 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting scheduled on 9th November 2017 |
Download
|
26th AGM Voting Results |
Download
|
Placement Document for QIP |
Download
|
Closing of QIP |
Download
|
Notice of QIP Committee Meeting scheduled on 25.09.2017 |
Download
|
Preliminary Placement Document for Proposed QIP |
Download
|
Opening of QIP |
Download
|
Notice of 26th AGM published on 6th Sep 2017 in Business Standard and Prajashakti |
Download
|
Notice of 26th AGM Scheduled on 28th September 2017 |
Download
|
Received EIR from US FDA to Gagillapur Facility |
Download
|
Notice of record date published in Business Standard and Prajashakti on 15.08.2017 |
Download
|
Q1 Results for the FY 2017-18 Published in Business Standard and Prajashakti on 15.08.2017 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q1-FY2017-18 |
Download
|
Outcome of Board Meeting held on 14th Aug 2017 |
Download
|
Notice of Board meeting published on 8th Aug 2017 in Business Standard and Prajashakti |
Download
|
Notice of Board Meeting Scheduled on 14th August 2017 |
Download
|
EGM voting Results-12.06.2017 |
Download
|
Notice of Extra-Ordinary General Meeting to be held on 12th June 2017 |
Download
|
e-voting Instructions for the EGM |
Download
|
Granules India’s Revenue increases 4% to Rs. 1,435 Cr.; Net Profit surges 34% to Rs. 165 Cr. Date: 11-05-2017 |
Download
|
Outcome of Board Meeting held on 11th May 2017 |
Download
|
Further notice of Board Meeting |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q4-FY2016-17 |
Download
|
Notice of Board Meeting Scheduled on 11th May 2017 |
Download
|
Outcome of 176th Board Meeting dated 28th January, 2017 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q3-FY2016-17 |
Download
|
Notice of Board Meeting Scheduled on 28th January 2017 |
Download
|
INFARMED inspection at Gagillapur facility |
Download
|
Appointment of Director |
Download
|
BSE Approval-Part B reg. Scheme of Amalgamation |
Download
|
Granules OmniChem facility completed U.S. FDA inspection |
Download
|
High Court Order for Amalgamation of GIL Lifesciences with Granules |
Download
|
Outcome of 174th Board Meeting dated 25th October 2016 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q2-FY2016-17 |
Download
|
Granules India’s Gagillapur facility successfully completed US FDA inspection |
Download
|
Notice of Board Meeting Scheduled on 25th October 2016 |
Download
|
Granules India Limited, received US FDA approval for Ibuprofen 200 mg Tablets |
Download
|
Schedule of Investor meet on 9th September 2016 |
Download
|
Q1 Results for the FY 2016-17 Published in Business Standard and Prajashakti on 13.08.2016 |
Download
|
25th AGM Voting Results |
Download
|
Outcome of 173rd Board Meeting Held on 11th August 2016 |
Download
|
Schedule of Analyst and Investors Earnings Conference call-Q1-FY2016-17 |
Download
|
Notice of Board Meeting |
Download
|
Date of Publication is on 14th July 2016 in Business Standard and Prajashakth |
Download
|
Intimation of Schedule of Investor Meeting |
Download
|
Intimation of Trading Window Closure |
Download
|
Compliant Report -BSE |
Download
|
BSE Observation letter from the scheme of amalgamation |
Download
|
NSE Observation letter from the scheme of amalgamation |
Download
|
Scheme of Amalgamation & Regulation 37 Documents |
Download
|
Q4 Results published in Business Standard and Prajashakti on 30.04.2016 |
Download
|
Outcome of 172nd Board Meeting Held on 28th April 2016 |
Download
|
Date of publication is on 15th April 2016 in Business standard and Prajashakti |
Download
|
Schedule of Analyst/Investors Earnings Conference call-Q4, FY 2015-16 |
Download
|
Notice of Board Meeting scheduled on April 28, 2016 |
Download
|
Intimation of Trading Window Closure |
Download
|
Intimation of Schedule of the Non Deal Road Show |
Download
|
Q3 Results published in Business Standard and Prajashakti on 29.01.2016 |
Download
|
Outcome of Board Meeting held on 28.01.2016 |
Download
|
Date of publication is on 20th January 2016 in Business standard and Prajashakti |
Download
|
Notice of Board Meeting scheduled on January 28, 2016 |
Download
|